Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yinqiao Baidu Tablet is a Traditional Chinese Medicine (TCM) formulation developed for the treatment of the common cold, specifically cases attributed to "exogenous wind-heat" in TCM theory. The product is designed to clear heat, resolve toxins, and relieve exterior symptoms such as fever, headache, cough, and sore throat. It is being further evaluated in Phase IV clinical trials by Beijing Tianli Zhengyuan Pharmaceutical Technology Development to confirm its efficacy and safety profile in a broader patient population. The formulation typically contains a blend of botanical extracts, including *Lonicera japonica* (honeysuckle) and *Forsythia suspensa*, which are traditionally utilized for their anti-inflammatory and antipyretic properties.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Yinqiao Baidu Tablet.